Chronic heart failure due to Qi deficiency and blood stasis and intervention mechanism of Compound Renshen Buqi Granules:a proteomics-based study.
10.19540/j.cnki.cjcmm.20210603.402
- Author:
Yu-Jie WU
1
;
Zhi-Bo WANG
2
;
Ying LI
2
;
Dao-Ping WANG
3
;
Lan MIAO
4
;
Jun-Guo REN
4
;
Ying-Hong PAN
3
;
Jian-Xun LIU
4
Author Information
1. Graduate School, Beijing University of Chinese Medicine Beijing 100029, China Institute of Basic Medical Science, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
2. Institute of Basic Medical Science, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China Institute of Crop Science, Chinese Academy of Agricultural Sciences Beijing 100081, China.
3. Institute of Crop Science, Chinese Academy of Agricultural Sciences Beijing 100081, China.
4. Institute of Basic Medical Science, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China Beijing Key Laboratory of Pharmacology of Traditional Chinese Medicine Beijing 100091, China.
- Publication Type:Journal Article
- Keywords:
Qi deficiency and blood stasis syndrome;
chronic heart failure(CHF);
disease-syndrome combination;
proteomics;
traditional Chinese medicine
- MeSH:
Animals;
Heart Failure/drug therapy*;
Medicine, Chinese Traditional;
Panax;
Proteomics;
Qi;
Rats;
Rats, Sprague-Dawley
- From:
China Journal of Chinese Materia Medica
2021;46(19):5052-5063
- CountryChina
- Language:Chinese
-
Abstract:
Compound Renshen Buqi Granules have been widely used to treat chronic heart failure(CHF) due to Qi deficiency and blood stasis, but the mechanism of action remains unclear. This paper explored the pathogenesis of CHF due to Qi deficiency and blood stasis and the intervention mechanism of Compound Renshen Buqi Granules based on quantitative proteomics for uncovering the biological basis. SD rats were divided into the normal control(N) group, normal+Compound Renshen Buqi Granules(ND) group, model(M) group, model+Compound Renshen Buqi Granules(D) group, and positive control(Y) group. The rat model of CHF due to Qi deficiency and blood stasis was established by ligation of the left anterior descending(LAD) coronary artery and chronic sleep deprivation. The rats in the ND group and D group were provided with Compound Renshen Buqi Granules, while those in the Y group received valsartan. Six weeks later, the serum was sampled and the data-dependent acquisition(DDA) was employed for the non-targeted quantitative proteomics analysis of the differences in protein expression among groups, followed by the targeted analysis of differentially expressed proteins(DEPs) generated by data-independent acquisition(DIA). Compared with the N group, the rats in the M group pre-sented with decreased body weight, grip strength, and pulse amplitude and increased RGB value on the tongue surface. The pathomorphological examination revealed inflammatory cell infiltration, cell degeneration and necrosis, tissue fibrosis, etc. After the intervention with Compound Renshen Buqi Granules, multiple indicators were reversed. As demonstrated by proteomics results, there were 144 and 111 DEPs found in the M group and ND group in comparison with the N group. Compared with the M group, 107 and 194 DEPs were found in the D group and the Y group, respectively. Compared with the ND group, 119 DEPs were detected in the D group. As illustrated by DIA-based verification, the quantitative results of six proteins in each group were consistent with those by DDA. The syndrome indicators and pathomorphological examination results demonstrated that the protein expression profile of rats with CHF due to Qi deficiency and blood stasis changed obviously. However, Compound Renshen Buqi Granules were able to reverse the differential expression of immune proteins to regulate CHF of Qi deficiency and blood stasis syndrome, which has provided clues for figuring out the pathogenesis of CHF due to Qi deficiency and blood stasis and the intervention mechanism of Compound Renshen Buqi Granules.
